Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.
Skip to main content

Research

Rachel Kerr
Adjuvant Colorectal Cancer

Rachel Kerr

Boris Vojnovic
Advanced Technology Development

Boris Vojnovic

Len Seymour
Anticancer Viruses and Cancer Vaccines

Len Seymour

Walter Bodmer
Cancer and Immunogenetics

Walter Bodmer

Nick La Thangue
Cancer Cell Cycle

Nick La Thangue

Sarah Blagden
Cancer Therapeutics and mRNA Dysregulation

Sarah Blagden

David Clynes
Cancer Therapeutics, DNA Damage & Repair

David Clynes

Vincenzo D'Angiolella
Cell Cycle and Ubiquitin Signalling

Vincenzo D'Angiolella

Eric O'Neill
Cell Signalling

Eric O'Neill

Tim Humphrey
Chromosome Integrity

Tim Humphrey

Francesca Buffa
Computational Biology and Integrative Genomics

Francesca Buffa

Andrew Blackford
DNA Damage & Disease

Andrew Blackford

DNA Damage and Repair

Peter McHugh

Kristijan Ramadan
DNA Damage Response

Kristijan Ramadan

Anne Kiltie
DNA Repair in Cancer Treatment

Anne Kiltie

Mark Middleton
Early Phase Clinical Trials & Melanoma Therapy

Mark Middleton

Nicola Sibson
Experimental Neuroimaging

Nicola Sibson

Madalena Tarsounas
Genome Stability and Tumourigenesis

Madalena Tarsounas

Benjamin Fairfax
Genomics of Inflammation and Cancer Immunology

Benjamin Fairfax

Adrian Harris
Hypoxia and Angiogenesis

Adrian Harris

Val Macaulay
IGF Group

Val Macaulay

Anderson Ryan
Lung Cancer Research

Anderson Ryan

Ruth Muschel
Mechanisms of Metastasis

Ruth Muschel

Gillies McKenna
Molecular Resistance to Treatments

Gillies McKenna

Maria Hawkins
New Technical Radiotherapy/Advanced Radiation Oncology

Maria Hawkins

Fergus Gleeson
Novel Clinical Imaging Research

Fergus Gleeson

Tom Brown
Nucleic Acids

Tom Brown

Mike Brady
Oncological Image Analysis

Mike Brady

Anna Schuh
Oxford Molecular Diagnostics

Anna Schuh

Frank Van Den Heuvel
Radiation Therapy Medical Physics

Frank Van Den Heuvel

Bart Cornelissen
Radiopharmaceuticals and Molecular Imaging

Bart Cornelissen

Katherine Vallis
Radiotherapeutics & Radioimaging

Katherine Vallis

Ester Hammond
Tumour Hypoxia

Ester Hammond

Geoffrey Higgins
Tumour Radiosensitivity

Geoffrey Higgins

Supporting academic research within and outside of the university, we provide specialist analytical chemistry support in the majority through HPLC-MS or HPLC-MS-MS techniques with additional UV-visible absorbance and fluorescence detection abilities.
Bioanalysis

Supporting academic research within and outside ...

The Early Phase Clinical Trials Unit (EPCTU) aims to support the translation of research findings in to clinical practice.
Early Phase Clinical Trials Unit

The Early Phase Clinical Trials Unit (EPCTU) aims ...

Flow cytometry determines the 'what', the 'where' and the 'how much' of material in cells, and is an important step in testing effects of drug interventions.
Flow Cytometry

Flow cytometry determines the 'what', the 'where' ...

The Live Tissue Facility is designed to boost the translational impact of oncological research without users having to independently create ethics applications and collection logistics.
Live Tissue Facility

The Live Tissue Facility is designed to boost the ...

The Mechanical Workshop delivers an on-site fabrication facility for custom-made, precision mechanical items for use in scientific research.
Mechanical Workshop

The Mechanical Workshop delivers an on-site ...

The Microscopy SRF aims to provide research groups with imaging technologies to investigate cellular processes both in vitro and in vivo.
Microscopy

The Microscopy SRF aims to provide research ...

The Oncology Clinical Trials Office (OCTO) provides clinical trial management support to investigators across the CRUK Oxford Centre to manage trials from concept to completion.
Oncology Clinical Trials Office (OCTO)

The Oncology Clinical Trials Office (OCTO) ...

The PET Radiochemistry and Radiopharmacy core supports radiochemistry-dependent research programmes and provide GMP-grade PET radiopharmaceuticals for clinical trials.
PET Radiochemistry and Radiopharmacy (PROx)

The PET Radiochemistry and Radiopharmacy core ...

State-of-the art-imaging research and service platforms for in vivo study of disease models.
Pre-Clinical Imaging

State-of-the art-imaging research and service ...

Proteomics studies proteins on a large scale. Proteins are vital to living organisms and their multi-functional characteristics act as potential targets for drug therapies. Therefore, proteomics can be used for biomarker and target discovery, drug profiling and target validation.
Proteomics

Proteomics studies proteins on a large scale. ...

The Radiation Biophysics Facility develops and supports a unique range of radiation resources and techniques along with providing associated expertise.
Radiation Biophysics

The Radiation Biophysics Facility develops and ...

We provide tools, skills and training on analysis of biomedical data. Our expertise covers areas ranging from applied statistics to computational and functional genomics.
The Bioinformatics Hub

We provide tools, skills and training on analysis ...

Translational Histopathology
Translational Histopathology

Key Research Links

Latest Research News

Professor Anna Schuh awarded funding from the NIHR RIGHT programme

The NIHR has invested £34 million of funding into global health research projects to tackle epilepsy, infection-related cancers and severe stigmatising skin diseases in low- and middle-income countries (LMICs).

A tempting new target for cancer therapy

Kristijan Ramadan and his group published a new article in The EMBO Journal today. The article adds new detail to the story of how our cells repair damage to our DNA.

Department of Oncology to collaborate with Crescendo Biologics

The Department of Oncology has signed up to collaborate with Crescendo Biologics Ltd (Crescendo), the drug developer of novel, targeted T cell enhancing therapeutics.

More news